NCT02086526 - Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 20, 2016

Study Completion Date

November 20, 2016

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG

Metformin

Approximately 37 patients will start metformin therapy 3 months after their visit 2. All other patients will receive metformin therapy at their visit 2.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester